FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,147,798 | -56.3% | 212,864 | -2.9% | 0.12% | -56.8% |
| Q3 2022 | $4,911,000 | -27.4% | 219,146 | -19.7% | 0.28% | -12.8% |
| Q2 2022 | $6,766,000 | -29.0% | 273,033 | +11.0% | 0.33% | -13.9% |
| Q1 2022 | $9,534,000 | -34.9% | 245,916 | -1.7% | 0.38% | -26.9% |
| Q4 2021 | $14,640,000 | -5.3% | 250,212 | -4.0% | 0.52% | -8.9% |
| Q3 2021 | $15,455,000 | -46.9% | 260,756 | -22.3% | 0.57% | -44.8% |
| Q2 2021 | $29,112,000 | -8.1% | 335,427 | -12.7% | 1.04% | +0.2% |
| Q1 2021 | $31,691,000 | -10.0% | 384,362 | -0.8% | 1.03% | -16.6% |
| Q4 2020 | $35,220,000 | +169.6% | 387,327 | +18.5% | 1.24% | +135.6% |
| Q3 2020 | $13,064,000 | – | 326,844 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |